These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11362798)
1. Abbott agrees to implement a compassionate use program for Ritonavir. J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798 [TBL] [Abstract][Full Text] [Related]
2. How 'bout that ritonavir? Notes Undergr; 1996 Jan; (no 31):5. PubMed ID: 11363356 [TBL] [Abstract][Full Text] [Related]
3. 2000 PWAs to get ritonavir via expanded access. J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363098 [TBL] [Abstract][Full Text] [Related]
4. Abbott protease inhibitor lottery in January, CD4 under 50--registration now. AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074 [TBL] [Abstract][Full Text] [Related]
14. Ritonavir for advanced HIV infection. Am Fam Physician; 1996 Jul; 54(1):372, 374. PubMed ID: 8677846 [No Abstract] [Full Text] [Related]
15. Abbott agrees to expanded access for ritonavir. Baker R BETA; 1995 Sep; ():4. PubMed ID: 11362891 [TBL] [Abstract][Full Text] [Related]
16. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
17. Protease inhibitors: patient education critical. James JS AIDS Treat News; 1996 Apr; (no 244):1-3. PubMed ID: 11363303 [TBL] [Abstract][Full Text] [Related]
18. Expanded access program for ABT-378 under way. Slovick J Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322 [TBL] [Abstract][Full Text] [Related]